Nuclear Medicine/Radiopharmaceuticals Global Market - Forecast to 2022

  • ID: 3639435
  • Report
  • Region: Global
  • 451 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 5

FEATURED COMPANIES

  • Ablynx Nv
  • Bracco Diagnostics Inc‘s
  • Eckert & Ziegler Strahlen
  • Iso Ray Medical Inc
  • Nordion Inc.
  • Sanofi
  • MORE
Over the past 50 years nuclear medicine sector has displayed a strong link between investments in chemistry and development of radionuclide’s and radiolabeled compounds. This advancement has majorly impacted the health care practice. In the present scenario nuclear medicine is considered to be one of the diagnostics and therapeutic modality technique for probing, tracking and treating disease-related tissue function, progression and treatment response.

Non-invasive nuclear medicine imaging technique provides functional information at both molecular and cellular level and helps measuring the uptake and turnover of target-specific radiotracers in tissue.

Radioisotopes are used in a wide variety of applications like oncology, cardiovascular and neurological disorders. But in recent times, advancements in the field of nuclear medicine and radioactive tracers have emerged to provide few practical methods for studying the limited metabolic activities of bones and teeth, hence has found a role in dental science research.

The global nuclear medicine/radiopharmaceutical market is expected to reach $9,275.3 million by 2022. Nuclear medicinal market is mainly classified into type (diagnosis & therapeutics), application and end-users. The global nuclear medicine market by diagnosis is further divided into SPECT and PET while therapeutics market is segmented into alpha radiation therapy, beta radiation therapy and brachytherapy.

The SPECT and PET diagnostics market is further divided into isotopes and application. SPECT market by isotopes includes technetium (Tc-99m), thallium (Tl-201), gallium (Ga-67), iodine (I-123), samarium (Sm-153), yttrium (Y-90), rhenium (Re-186) and others. SPECT by applications are classified into cardiology, gastro intestinal, oncology, nephrology, neurology, inflammation, thyroid glands, lymphology and others. The PET diagnostic market by isotopes involves fluorodeoxyglucose (18f-FDG), gallium (Ga-68), rubidium (Rb-82) and others. PET applications are segmented into cardiology, oncology, neurology, inflammation, thyroid and others.

The alpha radiation therapy includes actinium (Ac-225), astatine-211 (At-211), lead (Pb-212)/bismuth (Bi-212), radium (Ra-223), radium-224 (Ra-224), thorium-227 (Th-227) and others. The isotopes considered in beta radiation therapy are erbium (Er-169), iodine (I-131) lutetium (Lu-177), rhenium (Re-186), samarium (Sa-153), strontium (Sr-89), yttrium (Y-90) and others. The final therapeutic segment brachytherapy involves cesium (Cs-131), iodine (I-125), iridium (Ir-192), palladium (Pd-103) and others

The nuclear medicine market end-users include medical, academic research laboratories and industries. The end-users by medical further segmented into hospitals and diagnostic centers.

The nuclear medicine/radiopharmaceutical market includes stable isotopes section as well which is classified into isotopes and applications. Isotopes considered are carbon (C-13), deuterium (D2), oxygen (O-18), nitrogen (N-15), sulphur (S-32) and others. The stable isotopes have application in diagnostics and therapy, pharmaceutical companies, research section and industrial sector. The leading players of this market are Cambridge Isotope Laboratories (U.S) and Isotec Inc. subsidiary of Sigma Aldrich (U.S.).

The nuclear medicine/radiopharmaceuticals market is expected to grow at single digit CAGR during 2015 to 2022. The factors driving the growth of this market are increased application of radiopharmaceuticals, rise in public awareness, usage of hybrid imaging, abundance of radio pharmaceuticals, technological advancements; alpha radio immunotherapy based targeted cancer treatment and wide range of available products likely to propel the nuclear medicine market.

In addition to this, increasing need in emerging markets, production of radio pharmaceuticals from cyclotrons, efficient diagnosis and treatments, emerging radio isotopes, increasing therapeutic application areas and replacement of old/traditional equipment are some of the opportunities that are propelling the growth of the market. However, regulatory issues, high cost and supply shortage of isotopes, shorter half life of radiopharmaceuticals, and threat from traditional/alternative diagnostic procedures are hampering the growth of the market.

The threats for the nuclear medicine/radiopharmaceuticals market include huge capital investment and shortage of qualified technicians. The major problem area of nuclear medicine market is closure of reactors.

The nuclear medicine/radiopharmaceuticals global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the nuclear medicine market are Bayer Healthcare (Germany) Cardinal Health Inc. (U.S.), Cambridge Isotope Laboratories (U.S), GE Healthcare (U.K.), IBA Group (Belgium), Isotec Inc. (U.S.) Lantheus Medical Imaging (U.S.), Mallinckrodt Plc (Ireland), NTP Radioisotopes (South Africa), Nordion Inc (Canada) Siemens Healthcare (Germany) and Taiyo Nippon Sanso Corporation (Japan).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Ablynx Nv
  • Bracco Diagnostics Inc‘s
  • Eckert & Ziegler Strahlen
  • Iso Ray Medical Inc
  • Nordion Inc.
  • Sanofi
  • MORE
1 Executive Summary

2 Introduction
2.1 Key Take Aways
2.2 Report Description
2.3 Markets Covered
2.4 Stakeholders
2.5 Research Methodology
2.5.1 Market Size Estimation
2.5.2 Market Crackdown And Data Triangulation
2.5.3 Secondary Sources
2.5.4 Key Data Points From Secondary Sources
2.5.5 Primary Sources
2.5.6 Key Data Points From Primary Sources
2.5.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers & Opportunities
3.3.1.1 Increased Application Of Radiopharmaceuticals
3.3.1.2 Rise In Public Awareness
3.3.1.3 Usage Of Hybrid Imaging
3.3.1.4 Abundance Of Radiopharmaceuticals
3.3.1.5 Technological Advancements
3.3.1.6 Increasing Need In Emerging Markets
3.3.1.7 Production Of Radiopharmaceuticals From Cyclotrons
3.3.1.8 Efficient Diagnosis And Treatments
3.3.1.9 Emerging Radioisotopes
3.3.1.10 Increasing Therapeutic Application Areas
3.3.1.11 Replacement Of Old/Traditional Equipment
3.3.2 Restraints & Threats
3.3.2.1 Regulatory Issues
3.3.2.2 High Cost And Supply Shortage Of Isotopes
3.3.2.3 Shorter Half-Life Of Radiopharmaceuticals
3.3.2.4 Threat From Traditional/Alternative Diagnostic Procedures
3.3.2.5 Huge Capital Investment
3.3.2.6 Shortage Of Qualified Technicians
3.3.2.7 Radiotoxicity
3.4 Problem Areas
3.4.1 Closure Of Reactors
3.5 Winning Imperatives
3.5.1 Availability Of Technetium
3.6 Regulatory Guidelines
3.6.1 United States
3.6.2 Europe
3.6.3 Japan
3.6.4 China
3.6.5 South Korea
3.7 Reimbursement Scenario & Challenges
3.8 Patent Trends
3.9 Supply Chain Analysis
3.9.1 Reactors
3.9.2 Processing Facility
3.9.3 Generators Manufacturing Units
3.9.4 Hospitals And Central Radio Pharmacies
3.10 List Of Potential New Reactors
3.11 Porter's Five Force Analysis
3.11.1 Threat Of New Entrants
3.11.2 Threat Of Substitutes
3.11.3 Bargaining Power Of Suppliers
3.11.4 Bargaining Power Of Buyers
3.11.5 Competitive Rivalry
3.12 Market Share Analysis By Major Players
3.12.1 Nuclear Medicine Market
3.12.2 Stable Isotopes Market

4 Radiopharmaceuticals By Type
4.1 Introduction
4.2 Diagnostics
4.2.1 Radiopharmaceuticals For Diagnosis, By Isotopes
4.2.1.1 Spect, By Isotopes
4.2.1.1.1 Technetium (Tc-99M)
4.2.1.1.2 Thallium (Tl-201)
4.2.1.1.3 Gallium (Ga-67)
4.2.1.1.4 Iodine (I-123)
4.2.1.1.5 Samarium (Sm-153)
4.2.1.1.6 Yttrium (Y-90)
4.2.1.1.7 Rhenium (Re-186)
4.2.1.1.8 Others
4.2.1.2 Pet, By Isotopes
4.2.1.2.1 Fluorodeoxyglucose (Fdg)
4.2.1.2.2 Gallium (Ga-68)
4.2.1.2.3 Rubidium (Rb-82)
4.2.1.2.4 Others
4.2.2 Radiopharmaceuticals For Diagnosis, By Application
4.2.2.1 Spect By Application
4.2.2.1.1 Cardiology
4.2.2.1.2 Gastro Intestinal
4.2.2.1.3 Oncology
4.2.2.1.4 Nephrology
4.2.2.1.5 Neurology
4.2.2.1.6 Inflammation
4.2.2.1.7 Thyroid Glands
4.2.2.1.8 Lymphology
4.2.2.1.9 Others
4.2.2.2 Pet By Application
4.2.2.2.1 Oncology
4.2.2.2.2 Neurology
4.2.2.2.3 Cardiology
4.2.2.2.4 Inflammation
4.2.2.2.5 Others
4.3 Therapeutics
4.3.1 Radiopharmaceuticals For Therapeutics, By Type
4.3.1.1 Beta Radiation Therapy
4.3.1.1.1 Yttrium (Y-90)
4.3.1.1.2 Iodine (I-131)
4.3.1.1.3 Lutetium (Lu-177)
4.3.1.1.4 Samarium (Sm-153)
4.3.1.1.5 Rhenium (Re-186)
4.3.1.1.6 Strontium (Sr-89)
4.3.1.1.7 Erbium (Er-169)
4.3.1.1.8 Others
4.3.1.2 Alpha Radiation Therapy, By Isotopes
4.3.1.2.1 Actinium (Ac-225)
4.3.1.2.2 Astatine (At-211)
4.3.1.2.3 Lead (Pb-212)/Bismuth (Bi-212)
4.3.1.2.4 Radium-224
4.3.1.2.5 Radium-223
4.3.1.2.6 Thorium-227 (Th-227)
4.3.1.2.7 Others
4.3.1.3 Brachytherapy, By Isotopes
4.3.1.3.1 Iodine (I-125)
4.3.1.3.2 Cesium (Cs-131)
4.3.1.3.3 Iridium (Ir-192)
4.3.1.3.4 Palladium (Pd-103)
4.3.1.3.5 Others
4.3.2 Therapeutics Radiopharmaceuticals, By Application
4.3.2.1 Oncology
4.3.2.2 Nephrology
4.3.2.3 Cardiology
4.3.2.4 Neurology
4.3.2.5 Others

5 Global Nuclear Medicine Market By End-Users
5.1 Introduction
5.2 Medical
5.2.1 Hospitals
5.2.2 Diagnostic Centers
5.3 Academic Research Laboratories
5.4 Industries

6 Stable Isotopes
6.1 Introduction
6.2 Market Analysis
6.2.1 Factors Influencing Market
6.2.2 Drivers & Opportunities
6.2.2.1 Increased Use As Controlled Drug Standards
6.2.2.2 Increasing Medical Applications (Diagnostics & Therapeutics)
6.2.2.3 Increased Usage In Personalized Medicine & Pk Studies
6.2.2.4 System Biology And Proteomics Applications
6.2.2.5 Ecological And Environmental Studies
6.2.3 Restraints And Threats
6.2.3.1 High Cost Of Stable Isotopes
6.2.3.2 Stable Isotopes-Side Effects
6.2.3.3 Safety Issues Of Deuterium
6.3 Stable Isotopes Market, By Isotopes
6.3.1 Carbon (C-13)
6.3.2 Deuterium (D2)
6.3.3 Oxygen (O-18)
6.3.4 Nitrogen (N-15)
6.3.5 Sulphur (S-32)
6.3.6 Others
6.4 Stable Isotopes Market, By Applications
6.4.1 Diagnostics And Therapy
6.4.2 Pharmaceuticals
6.4.3 Research
6.4.4 Industrial Sector
6.5 Stable Isotopes Market, By Geography
6.5.1 Introduction
6.5.2 North America
6.5.3 Europe
6.5.4 Asia-Pacific
6.5.5 Rest Of The World

7 Regional Analysis
7.1 Introduction
7.2 North America
7.3 Europe
7.4 Asia-Pacific
7.5 Rest Of The World

8 Competitive Landscape
8.1 Introduction
8.2 New Product Launches
8.3 Agreements, Partnership, Collaboration & Joint Ventures
8.4 Approvals
8.5 Expansions
8.6 Mergers & Acquisitions
8.7 Other Developments

9 Major Player Profiles
9.1 Bayer Healthcare
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Key Developments
9.1.5 Business Strategy
9.1.6 Swot Analysis
9.2 Cardinal Health Inc.
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Key Developments
9.2.5 Business Strategy
9.2.6 Swot Analysis
9.3 Cambridge Isotope Laboratories Inc.
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Key Developments
9.3.5 Business Strategy
9.3.6 Swot Analysis
9.4 Ge Healthcare
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Key Developments
9.4.5 Business Srategy
9.4.6 Swot Analysis
9.5 Iba Group
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Key Developments
9.5.5 Business Strategy
9.5.6 Swot Analysis
9.6 Isotec Inc
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Key Developments
9.6.5 Business Strategy
9.6.6 Swot Analysis
9.7 Lantheus Medical Imaging Inc.
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Key Developments
9.7.5 Business Strategy
9.7.6 Swot Analysis
9.8 Mallinckrodt Plc
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Key Developments
9.8.5 Business Strategy
9.8.6 Swot Analysis
9.9 Nordion Inc
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Key Developments
9.9.5 Business Strategy
9.9.6 Swot Analysis
9.10 Ntp Radioisotopes Soc Ltd
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Key Developments
9.10.5 Business Strategy
9.10.6 Swot Analysis
9.11 Siemens Healthcare
9.11.1 Overview
9.11.2 Financials
9.11.3 Product Portfolio
9.11.4 Key Developments
9.11.5 Business Strategy
9.11.6 Swot Analysis
9.12 Taiyo Nippon Sanso Corporation
9.12.1 Overview
9.12.2 Financials
9.12.3 Product Portfolio
9.12.4 Key Developments
9.12.5 Business Strategy
9.12.6 Swot Analysis

List Of Tables
Table 1 Nuclear Medicine Global Market Revenue By Region, (2014-2022) ($Mn)
Table 2 Reimbursement Rates For Bone Scans In United States
Table 3 Reimbursement Rates For Radiopharmaceuticals And Diagnostic Imaging Techniques
Table 4 Technetium (Tc-99M) Reactors
Table 5 New Potential Reactors
Table 6 Nuclear Medicine Global Market Revenue, By Type, (2014-2022) ($Mn)
Table 7 Nuclear Medicine Diagnostics Global Market Revenue, By Type, (2014-2022) ($Mn)
Table 8 Nuclear Medicine Spect Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 9 Nuclear Medicine Pet Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 10 Nuclear Medicine Spect Global Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 11 Spect Technetium (Tc-99M) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 12 Spect Thallium (Tl-201) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 13 Spect Gallium (Ga-67) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 14 Spect Iodine (I-123) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 15 Spect Samarim (Sm-153) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 16 Spect Yttrium (Y-90) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 17 Spect Rhenium (Re-186) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 18 Spect Other Isotopes Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 19 Nuclear Medicine Pet Global Market Revenue, By Isotopes, (2014-2022) ($Mn)
Table 20 Pet Fluorodeoxyglucose (18F-Fdg) Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 21 Pet Gallium (Ga-68) Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 22 Pet Rubidium (Rb-82) Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 23 Pet Other Isotopes Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 24 Nuclear Medicine Spect Global Market Revenue, By Application, (2014-2022) ($Mn)
Table 25 Spect Cardiology Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 26 Spect Gastrointestinal Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 27 Spect Oncology Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 28 Spect Nephrology Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 29 Spect Neurology Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 30 Spect Inflammation Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 31 Spect Thyroid Glands Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 32 Spect Lymphology Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 33 Spect Other Applications Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 34 Nuclear Medicine Pet Global Market Revenue, By Application, (2014-2022) ($Mn)
Table 35 Pet Oncology Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 36 Pet Neurology Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 37 Pet Cardiology Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 38 Pet Inflammation Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 39 Pet Inflammation Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 40 Nuclear Medicine Therapeutics Global Market Revenue, By Type, (2014-2022) ($Mn)
Table 41 Beta Radiation Therapy Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 42 Beta Radiation Therapy Global Market Revenue, By Isotopes, (2014-2022) ($Mn)
Table 43 Beta Radiation Therapy Yttrium (Y-90) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 44 Beta Radiation Therapy Iodine(I-131) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 45 Beta Radiation Therapy Lutetium (Lu-177) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 46 Beta Radiation Therapy Samarium (Sm-153) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 47 Beta Radiation Therapy Rhenium (Re-186) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 48 Beta Radiation Therapy Strontium (Sr-89) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 49 Beta Radiation Therapy Erbium (Er-169) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 50 Beta Radiation Therapy Other Isotopes Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 51 Alpha Radiation Therapy Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 52 Brachytherapy Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 53 Brachytherapy Global Market Revenue, By Isotopes, (2014-2022) ($Mn)
Table 54 Brachytherapy Iodine (I-125) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 55 Brachytherapy Cesium (Cs-131) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 56 Brachytherapy Iridium (Ir-192) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 57 Brachytherapy Palladium (Pd-103) Isotope Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 58 Brachytherapy Other Isotopes Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 59 Nuclear Medicine Global Market Revenue, By Application, (2014-2022) ($Mn)
Table 60 Nuclear Medicine Therapeutics Oncology Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 61 Nuclear Medicine Therapeutics Nephrology Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 62 Nuclear Medicine Therapeutics Cardiology Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 63 Nuclear Medicine Therapeutics Neurology Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 64 Nuclear Medicine Therapeutics Other Applications Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 65 Nuclear Medicine Global Market Revenue, By End-Users, (2014-2022) ($Mn)
Table 66 Nuclear Medicine (Medical) End-Users Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 67 Nuclear Medicine (Medical) End-Users Global Market Revenue, By Type, (2014-2022) ($Mn)
Table 68 Nuclear Medicine Hospital End-Users Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 69 Nuclear Medicine Diagnostic Centres End-User Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 70 Nuclear Medicine Academic Research Laboratories End-User Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 71 Nuclear Medicine Industries End-User Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 72 Stable Isotopes Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 73 Stable Isotopes Global Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 74 Stable Isotopes Carbon (C-13) Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 75 Stable Isotopes Deuterium (D2) Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 76 Stable Isotopes Oxygen (O-18) Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 77 Stable Isotopes Nitrogen (N-15) Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 78 Stable Isotopes Sulphur (S-32) Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 79 Stable Other Isotopes Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 80 Stable Isotopes Global Market Revenue, By Application, (2014-2022) ($Mn)
Table 81 Stable Isotopes Diagnostics &Therapy Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 82 Stable Isotopes Pharmaceuticals Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 83 Stable Isotopes Research Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 84 Stable Isotopes Industrial Sector Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 85 Stable Isotopes Industrial Sector Application Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 86 North American Stable Isotopes Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 87 North American Stable Isotopes Market Revenue, By Application, (2014-2022) ($Mn)
Table 88 European Stable Isotopes Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 89 European Stable Isotopes Market Revenue, By Application, (2014-2022) ($Mn)
Table 90 Asia-Pacific Stable Isotopes Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 91 Asia-Pacific Stable Isotopes Market Revenue, By Application, (2014-2022) ($Mn)
Table 92 Rest Of The World Stable Isotopes Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 93 Rest Of The World Stable Isotopes Market Revenue, By Application, (2014-2022) ($Mn)
Table 94 Nuclear Medicine Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 95 North American Nuclear Medicine Market Revenue, By Type, (2014-2022) ($Mn)
Table 96 North American Nuclear Medicine Diagnostics Market Revenue, By Type, (2014-2022) ($Mn)
Table 97 North American Nuclear Medicine Spect Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 98 North American Nuclear Medicine Pet Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 99 North American Nuclear Medicine Spect Market Revenue, By Application, (2014-2022) ($Mn)
Table 100 North American Nuclear Medicine Pet Market Revenue, By Application, (2014-2022) ($Mn)
Table 101 North American Nuclear Medicine Therapeutics Market Revenue, By Type, (2014-2022) ($Mn)
Table 102 North American Nuclear Medicine Beta Radiation Therapy Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 103 North American Nuclear Medicine Brachytherapy Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 104 North American Nuclear Medicine Therapeutics Market Revenue, By Application, (2014-2022) ($Mn)
Table 105 North American Nuclear Medicine Market Revenue, By End-Users, (2014-2022) ($Mn)
Table 106 North American Nuclear Medicine (Medical) End-Users Market Revenue, By Type, (2014-2022) ($Mn)
Table 107 European Nuclear Medicine Market Revenue, By Type, (2014-2022) ($Mn)
Table 108 European Nuclear Medicine Diagnostics Market Revenue, By Type, (2014-2022) ($Mn)
Table 109 European Nuclear Medicine Spect Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 110 European Nuclear Medicine Pet Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 111 European Nuclear Medicine Spect Market Revenue, By Application, (2014-2022) ($Mn)
Table 112 European Nuclear Medicine Pet Market Revenue, By Application, (2014-2022) ($Mn)
Table 113 European Nuclear Medicine Therapeutics Market Revenue, By Type, (2014-2022) ($Mn)
Table 114 European Nuclear Medicine Beta Radiation Therapy Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 115 European Nuclear Medicine Brachytherapy Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 116 European Nuclear Medicine Therapeutics Market Revenue, By Application, (2014-2022) ($Mn)
Table 117 European Nuclear Medicine Market Revenue, By End-Users, (2014-2022) ($Mn)
Table 118 European Nuclear Medicine (Medical) End-Users Market Revenue, By Type, (2014-2022) ($Mn)
Table 119 Asia-Pacific Nuclear Medicine Market Revenue, By Type, (2014-2022) ($Mn)
Table 120 Asia-Pacific Nuclear Medicine Diagnostics Market Revenue, By Type, (2014-2022) ($Mn)
Table 121 Asia-Pacific Nuclear Medicine Spect Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 122 Asia-Pacific Nuclear Medicine Pet Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 123 Asia-Pacific Nuclear Medicine Spect Market Revenue, By Application, (2014-2022) ($Mn)
Table 124 Asia-Pacific Nuclear Medicine Pet Market Revenue, By Application, (2014-2022) ($Mn)
Table 125 Asia-Pacific Nuclear Medicine Therapeutics Market Revenue, By Type, (2014-2022) ($Mn)
Table 126 Asia-Pacific Nuclear Medicine Beta Radiation Therapy Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 127 Asia-Pacific Nuclear Medicine Brachytherapy Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 128 Asia-Pacific Nuclear Medicine Therapeutics Market Revenue, By Application, (2014-2022) ($Mn)
Table 129 Asia-Pacific Nuclear Medicine Market Revenue, By End-Users, (2014-2022) ($Mn)
Table 130 Asia-Pacific Nuclear Medicine (Medical) End-Users Market Revenue, By Type, (2014-2022) ($Mn)
Table 131 Rest Of The World Nuclear Medicine Market Revenue, By Type, (2014-2022) ($Mn)
Table 132 Rest Of The World Nuclear Medicine Diagnostics Market Revenue, By Type, (2014-2022) ($Mn)
Table 133 Rest Of The World Nuclear Medicine Spect Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 134 Rest Of The World Nuclear Medicine Pet Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 135 Rest Of The World Nuclear Medicine Spect Market Revenue, By Application, (2014-2022) ($Mn)
Table 136 Rest Of The World Nuclear Medicine Pet Market Revenue, By Application, (2014-2022) ($Mn)
Table 137 Rest Of The World Nuclear Medicine Therapeutics Market Revenue, By Type, (2014-2022) ($Mn)
Table 138 Rest Of The World Nuclear Medicine Beta Radiation Therapy Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 139 Rest Of The World Nuclear Medicine Brachytherapy Market Revenue, By Isotope, (2014-2022) ($Mn)
Table 140 Rest Of The World Nuclear Medicine Therapeutics Market Revenue, By Application, (2014-2022) ($Mn)
Table 141 Rest Of The World Nuclear Medicine Market Revenue, By End-Users, (2014-2022) ($Mn)
Table 142 Rest Of The World Nuclear Medicine (Medical) End-Users Market Revenue, By Type, (2014-2022) ($Mn)
Table 143 New Product Launches (2013-2015)
Table 144 Agreements, Partnership, Collaboration & Joint Ventures, (2013-2015)
Table 145 Approvals (2013-2015)
Table 146 Expansions (2013-2015)
Table 147 Mergers & Acquisitions (2013-2015)
Table 148 Other Developments (2013-2015)
Table 149 Bayer Healthcare: Total Revenue And R&D Expenses, (2013-2015) ($Mn)
Table 150 Bayer Healthcare: Total Revenue, By Segments, (2013-2015) ($Mn)
Table 151 Bayer Healthcare: Total Revenue, By Geography, (2013-2015) ($Mn)
Table 152 Cardinal Health, Inc.: Total Revenue And Operating Expenses (2013-2015) ($Mn)
Table 153 Cardinal Health, Inc.: Total Revenue, By Segments, (2013-2015) ($Mn)
Table 154 Cardinal Health, Inc.: Total Revenue, By Geography, (2013-2015) ($Mn)
Table 155 General Electric Company: Total Revenue And R&D Expenses, (2013 – 2015) ($Mn)
Table 156 General Electric Company: Total Revenue, By Segments, (2013-2015) ($Mn)
Table 157 General Electric Company: Total Revenue, By Geography, (2013 – 2015) ($Bn)
Table 158 Iba Group: Total Revenue And R&D Expenses (2013 - 2015) ($Mn)
Table 159 Iba Group: Total Revenue, By Segments (2013-2015) ($Mn)
Table 160 Iba Group: Total Revenue, By Geography (2012 – 2014) ($Mn)
Table 161 Isotec, Inc: Total Revenue And R&D Expenses (2013-2015) ($Mn)
Table 162 Isotec, Inc: Total Revenue, By Segments (2013-2015) ($Mn)
Table 163 Isotec, Inc: Total Revenue, By Geography (2012-2014) ($Mn)
Table 164 Lantheus Medical Imaging Inc.: Total Revenue And R&D Expenses, (2013-2015) ($Mn)
Table 165 Lantheus Medical Imaging Inc.: Total Revenue, By Products (2013-2015) ($Mn)
Table 166 Lantheus Medical Imaging Inc.: Total Revenue, By Geography (2013-2015) ($Mn)
Table 167 Mallinckrodt Plc: Total Sales And R&D Expenses, (2013-2015) ($Mn)
Table 168 Mallinckrodt Plc: Total Revenue, By Segments, (2013- 2015) ($Bn)
Table 169 Mallinckrodt Plc: Total Revenue, By Geography, (2013- 2015) ($Mn)
Table 170 Siemens Ag: Total Revenue And R&D Expenses, (2013-2015) ($Mn)
Table 171 Siemens Ag: Total Revenue, By Segments, (2013-2015) ($Mn)
Table 172 Siemens Ag: Total Revenue, By Geography, (2013-2015) ($Mn)
Table 173 Taiyo Nippon Sanso Corporation: Total Revenue And R&D Expenses (2013-2015) ($Mn)
Table 174 Taiyo Nippon Sanso Corporation: Total Revenue, By Segments (2013-2015) ($Mn)
Table 175 Taiyo Nippon Sanso Corporation: Total Revenue, By Geography (2013-2015) ($Mn)

List Of Figures
Figure 1 Nuclear Medicine Global Market Share And Revenue, By Region, (2014-2022)
Figure 2 Nuclear Medicine Global Market: Research Approach
Figure 3 Nuclear Medicine Globalmarket: Top-Down And Bottom-Up Approach
Figure 4 Nuclear Medicine Global Market: Forecasting Model
Figure 5 Nuclear Medicine Global Market: Market Crackdown And Data Triangulation
Figure 6 Nuclear Medicine Global Market: Market Segmentation
Figure 7 Stable Isotopes Global Market: Market Segmentation
Figure 8 Market Dynamics
Figure 9 Nuclear Medicine Global Market: Pct Patent Filing By Major Players (2011-2015)
Figure 10 Nuclear Medicine Global Market: United States Patent Filing By Major Players (2011-2015)
Figure 11 Technetium -99: Supply Chain Analysis
Figure 12 Nuclear Medicine Market: Porter’S Analysis
Figure 13 Nuclear Medicine Global Market Share Analysis, By Key Players, 2015 (%)
Figure 14 Stable Isotopes Market: Major Player Analysis (2015) (%)
Figure 15 Nuclear Medicine Global Market Revenue, By Type, (2014-2022) ($Mn)
Figure 16 Nuclear Medicine Diagnostics Global Market Revenue, By Type, (2015 V’S 2022) (%)
Figure 17 Nuclear Medicine Spect Global Market Revenue, By Isotope, (2015 V’S 2022) ($Mn)
Figure 18 Nuclear Medicine Pet Global Market Revenue, By Isotope, (2015 V’S 2022) ($Mn)
Figure 19 Nuclear Medicine Spect Global Market Revenue, By Application, (2015 V’S 2022) ($Mn)
Figure 20 Nuclear Medicine Pet Global Market Revenue, By Application, (2015 V’S 2022) ($Mn)
Figure 21 Nuclear Medicine Therapeutics Global Market Revenue, By Type, (2015 V’S 2022) ($Mn)
Figure 22 Nuclear Medicine Beta Radiation Therapy Global Market Revenue, By Isotope, (2015 V’S 2022) ($Mn)
Figure 23 Nuclear Medicine Brachytherapy Global Market Revenue, By Isotope, (2015 V’S 2022) ($Mn)
Figure 24 Nuclear Medicine Therapeutics Global Market Revenue, By Application, (2015 V’S 2022) ($Mn)
Figure 25 Nuclear Medicine Global Market Revenue, By End-Users, (2014-2022) ($Mn)
Figure 26 Stable Isotopes Market: Market Dynamics
Figure 27 Stable Isotopes Global Market Revenue, By Isotope, (2015) (%)
Figure 28 Stable Isotopes Global Market Revenue, By Application, (2015 V’S 2022) ($Mn)
Figure 29 Stable Isotopes Global Market Revenue, By Geography, (2014-2022) ($Mn)
Figure 30 North American Stable Isotopes Market Revenue, By Isotopes & Applications (2015 V’S2022) ($Mn)
Figure 31 European Stable Isotopes Market Revenue, By Isotopes & Applications (2015 V’S 2022) ($Mn)
Figure 32 Asia-Pacific Stable Isotopes Market Revenue, By Isotopes & Applications (2015 V’S 2022) ($Mn)
Figure 33 Rest Of The World Stable Isotopes Market Revenue, By Isotopes & Applications (2015-2022) ($Mn)
Figure 34 Nuclear Medicine Global Market Revenue, By Region, (2014-2022) ($Mn)
Figure 35 North American Spect, Pet Market Revenue, By Isotope, (2015 V’S 2022) ($Mn)
Figure 36 North American Spect, Pet Market Revenue, By Application, (2015 V’S 2022) ($Mn)
Figure 37 North American Nuclear Medicine Therapeutics Market Revenue, By Type, By Applications, Beta, Brachytherapy By Isotopes, (2015 V’S 2022) ($Mn)
Figure 38 European Spect, Pet Market Revenue, By Isotope, (2015 V’S 2022) ($Mn)
Figure 39 European Spect, Pet Market Revenue, By Application, (2015 V’S 2022) ($Mn)
Figure 40 European Nuclear Medicine Therapeutics Market Revenue, By Type, By Applications, Beta, Brachytherapy By Isotopes, (2015 V’S 2022) ($Mn)
Figure 41 Asia-Pacific Spect, Pet Market Revenue, By Isotope, (2015 V’S 2022) ($Mn)
Figure 42 Asia-Pacific Spect, Pet Market Revenue, By Application, (2015 V’S 2022) ($Mn)
Figure 43 Asia-Pacific Nuclear Medicine Therapeutics Market Revenue, By Type, By Applications, Beta, Brachytherapy By Isotopes, (2015 V’S 2022) ($Mn)
Figure 44 Row Spect, Pet Market Revenue, By Isotopes, (2015 V’S 2022) ($Mn)
Figure 45 Row Spect, Pet Market Revenue, By Applications, (2015 V’S 2022) ($Mn)
Figure 46 Row Nuclear Medicine Therapeutics Market Revenue, By Type, By Applications, Beta, Brachytherapy By Isotopes, (2015 V’S 2022) ($Mn)
Figure 47 Key Growth Strategies (2013 – 2015)
Figure 48 Swot: Bayer Healthcare
Figure 49 Swot: Cardinal Health, Inc.
Figure 50 Swot: Cambridge Isotope Laboratories Inc.
Figure 51 Swot: Ge Healthcare
Figure 52 Swot: Iba Group
Figure 53 Swot: Isotec Inc
Figure 54 Swot: Lantheus Medical Imaging Inc.
Figure 55 Swot: Mallinckrodt Plc
Figure 56 Swot: Nordion Inc
Figure 57 Swot: Ntp Radioisotopes Soc Ltd
Figure 58 Swot: Siemens Healthcare
Figure 59 Swot: Taiyo Nippon Sanso Corporation
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Ablynx Nv
- Abx Gmbh
- Actinium Pharmaceuticals, Inc
- Advanced Accelerator Applications
- Advanced Medical Isotope Corporation
- Affibody Ab
- Algeta Asa
- Aptuit
- Areva Med
- Arronax
- Auspex Pharmaceuticals
- Bard Medicals
- Bavarian Nordic
- Bayer Healthcare
- Best Medical International, Inc
- Bio Analytical Research Corporation Laboratories
- Bio-Nucleonics,Inc
- Bracco Diagnostics Inc‘s
- Btg International Ltd
- Bv Cyclotron Vu
- Cambridge Isotope Laboratories Inc.
- Cardinal Health Inc.
- Cellectar Biosciences
- Centre For Probe Development And Commercialization
- China Isotope Corporation
- Clarity’S Pharmaceuticals
- Coqui Pharmaceuticals
- Cortecnet
- Cp Medical
- Digirad Corporation
- Draximage Inc.
- Eckert & Ziegler Strahlen
- Eden Radioisotopes Llc
- Eli Lilly & Co
- Eurisotop
- Fujifilm Corporation
- Ge Healthcare
- Huayi Isotopes Co
- Iba Group
- Ibt-Bebig
- Idb Holland Bv
- Immunomedics
- Industrial Nuclear Company
- International Isotopes Inc.
- Invap S.E
- Iso Ray Medical Inc
- Iso Therapeutics Group, Llc
- Iso-Analytical Ltd
- Isoaid Llc
- Isoflex Isotope
- Isorad Ltd
- Isotec Inc
- Isotope Technologies Garching
- Ithemba Labs
- Joint Stock Company Isotope
- Lantheus Medical Imaging Inc
- Linde Group
- Mallinckrodt Plc
- Medi-Physics, Inc
- Medical Isotopes, Inc
- Mediso Medical Imaging Systems
- Memorial Sloan Kettering Cancer Center
- Navidea Biopharmaceuticals Inc
- Nihon Medi Physics Co Ltd
- Nordion Inc.
- Northstar Medical Technologies
- Ntp Radioisotopes Soc Ltd
- Octreopharm Sciences Gmbh
- Ostuka Pharmaceuticals Co Ltd
- Pars Isotope
- Peregrine Pharmaceuticals, Inc
- Perkin Elmer
- Perma-Fix Medical Sa
- Petnet Solution
- Philips Health Care
- Positron Corporation
- Radiomedix, Inc.
- Rotem Medical
- Royal Philips Electronics
- Sanofi
- Sercon Australia Pvt Ltd
- Sercon Ltd
- Shangai Research Institute Of Chemical Industry
- Shine Medical Technologies, Inc
- Siemens Healthcare
- Sievert
- Sirtex
- Source Production And Equipment Company+F191
- Spectrum Pharmaceuticals, Inc
- Spepharm Ag
- Stb Isotope Germany Gmbh
- Sterigenics International
- Steripet
- Tayyo Nippon Sanso Corporation
- Theragenics Corporation
- Thermo Fisher Scientific
- Toshiba Medical Systems Corporation
- Tracerco
- Trigon Biotechnology Inc
- Urenco
- Westinghouse Electric Company
- Zevacor Molecular
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll